Statistics for The Effectiveness and Safety of Neoadjuvant Pertuzumab and Trastuzumab in Women With Locally Advanced, Inflammatory, or Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Turkish Oncology Group Study
Total visits
| views | |
|---|---|
| The Effectiveness and Safety of Neoadjuvant Pertuzumab and Trastuzumab in Women With Locally Advanced, Inflammatory, or Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Turkish Oncology Group Study | 1 |
Total visits per month
| views | |
|---|---|
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 1 |
| February 2026 | 0 |
| March 2026 | 0 |
Top country views
| views | |
|---|---|
| Hong Kong SAR China | 1 |
Top city views
| views | |
|---|---|
| Hong Kong | 1 |